Orford Keith's Form 4 filing
Calithera Biosciences, Inc. (CALA) · filed Nov 9, 2021
- Accession no.
- 0000899243-21-043693
- Filed
- Nov 9, 2021
- Trade date
- Nov 5-9, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $43.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Orford KeithCIK 0001670740 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2021 | Common Stock | AGrant or awardAcquired | +30,000 | $0.00 | $0 | 196,094 | Direct | |
| Nov 9, 2021 | Common Stock | SSaleDisposed | −51,810 | $0.84 | −$43,520.4 | 144,284 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.